BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28355579)

  • 1. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
    J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
    Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
    J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies against BKPyV subtype I and IV in kidney transplant recipients and in the general Czech population.
    Hejtmánková A; Roubalová K; Forejtová A; Žáčková Suchanová J; Forstová J; Viklický O; Španielová H
    J Med Virol; 2019 May; 91(5):856-864. PubMed ID: 30609063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
    Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
    Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia.
    Saláková M; Ludvíková V; Hamšíková E; Kolářová M; Šroller V; Viklický O; Wohlfahrtová M
    Front Immunol; 2022; 13():929946. PubMed ID: 35967393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.
    Cioni M; Leboeuf C; Comoli P; Ginevri F; Hirsch HH
    Am J Transplant; 2016 Apr; 16(4):1193-206. PubMed ID: 26663765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex analysis of Human Polyomavirus diversity in kidney transplant recipients with BK virus replication.
    Wang Y; Strassl R; Helanterä I; Aberle SW; Bond G; Hedman K; Weseslindtner L
    J Clin Virol; 2019 Nov; 120():6-11. PubMed ID: 31505316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation.
    Bae H; Jung S; Chung BH; Yang CW; Oh EJ
    Front Immunol; 2023; 14():1243912. PubMed ID: 37809095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.
    Satyanarayana G; Hammond SP; Broge TA; Mackenzie MR; Viscidi R; Politikos I; Koralnik IJ; Cutler CS; Ballen K; Boussiotis V; Marty FM; Tan CS
    Transpl Immunol; 2015 Mar; 32(2):116-20. PubMed ID: 25536223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.